Physician profile
Mark Peal Posner
NPI 1255391660
$5,662.88
in general payments reported to CMS, 2019-2025
41 companies · $620 in 2025
The $620 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $563 · 2021: $887 · 2022: $916 · 2023: $1,046 · 2024: $891 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,557.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $839.09 | 2019-2025 | |
| Astellas Pharma US INC | $779.85 | 2019-2025 | Xtandi |
| Allergan, INC. | $461.33 | 2019-2022 | |
| Antares Pharma, INC. | $357.54 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Teleflex LLC | $342.24 | 2022-2023 | Urolift |
| Pfizer INC. | $322.05 | 2019-2025 | |
| Boston Scientific Corporation | $300.78 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Ams 700 Cxr Rte Kit |
| Janssen Biotech, INC. | $275.46 | 2019-2025 | Erleada |
| Blue Earth Diagnostics | $235.97 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $227.75 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $170.45 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $131.29 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $113.72 | 2019-2022 | |
| Axonics, INC. | $107.66 | 2022-2024 | Axonics, Bulkamid |
| Accord Healthcare, INC. | $82.69 | 2022-2023 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $82.26 | 2020-2025 | Fasenra, Lynparza |
| Ferring Pharmaceuticals INC. | $71.86 | 2019-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $68.71 | 2021-2024 | Pylarify |
| Endo Pharmaceuticals INC. | $64.22 | 2019-2022 | |
| Coloplast Corp | $60.00 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $57.55 | 2019-2020 | |
| Myovant Sciences INC. | $45.71 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $44.44 | 2021-2023 | Keytruda, Lynparza |
| Travere Therapeutics, INC. | $42.87 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $40.79 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Mission Pharmacal Company | $37.37 | 2022-2023 | |
| Neotract INC. | $29.92 | 2019-2020 | |
| Clarus Therapeutics INC. | $28.45 | 2021 | |
| Rochester Medical Corporation | $28.15 | 2019-2020 | |
| Procept Biorobotics Corporation | $25.73 | 2021 | |
| Photocure INC | $24.61 | 2022-2023 | Cysview |
| Myriad Genetic Laboratories, INC. | $23.22 | 2024 | Prolaris |
| Urovant Sciences INC | $21.87 | 2022 | |
| Agiliti Surgical, INC. | $18.79 | 2019 | |
| Novo Nordisk INC | $18.24 | 2024 | Rivfloza |
| Olympus America INC. | $16.13 | 2025 | Itind System |
| Kerecis Limited | $15.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ethicon US, LLC | $14.10 | 2020 | |
| Verity Pharmaceuticals INC. | $13.89 | 2024 | Trelstar |
| Halozyme INC | $13.32 | 2023 | |
| Ambu INC. | $7.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Posner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.